- Home
- XERS vs GNK Comparison
XERS vs GNK Comparison
Compare XERS & GNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XERS | GNK |
|---|---|---|
| Founded | 2005 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 967.7M |
| IPO Year | 2021 | 2005 |
Fundamental Metrics
Financial Performance| Metric | XERS | GNK |
|---|---|---|
| Price | $6.39 | $24.76 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 2 |
| Target Price | $10.83 | ★ $19.00 |
| AVG Volume (30 Days) | ★ 1.6M | 270.0K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 3.90% |
| EPS Growth | ★ 100.00 | N/A |
| EPS | 0.01 | ★ 0.21 |
| Revenue | $49,590,000.00 | ★ $342,054,000.00 |
| Revenue This Year | $34.37 | $21.15 |
| Revenue Next Year | $22.86 | $1.41 |
| P/E Ratio | $636.50 | ★ $117.86 |
| Revenue Growth | ★ 142.67 | N/A |
| 52 Week Low | $4.30 | $12.66 |
| 52 Week High | $10.08 | $27.25 |
Technical Indicators
Market Signals| Indicator | XERS | GNK |
|---|---|---|
| Relative Strength Index (RSI) | 54.88 | 51.93 |
| Support Level | $6.26 | $22.40 |
| Resistance Level | $6.41 | N/A |
| Average True Range (ATR) | 0.29 | 0.87 |
| MACD | 0.01 | 0.05 |
| Stochastic Oscillator | 38.65 | 35.12 |
Price Performance
Historical ComparisonAbout XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offers Recorlev for the treatment of endogenous hypercortisolemia in patients with Cushing's syndrome; Gvoke for the treatment of severe hypoglycemia; and Keveyis for the treatment of Primary Periodic Paralysis (PPP). Additionally, the company is advancing its Phase 3-ready pipeline product, XP-8121, a once-weekly subcutaneous injection of levothyroxine, which leverages its proprietary technology, XeriSol.
About GNK Genco Shipping & Trading Limited New (Marshall Islands)
Genco Shipping & Trading Ltd is an international shipping company specializing in the transportation of iron ore, coal, grain, steel products and other drybulk cargoes. It is involved in the ocean transportation of drybulk cargoes. The company operates in one segment, with two reportable segment: Major and Minor bulk fleet. It generates revenue through time charter agreements, spot market voyage charters, pool agreements and spot market-related time charters. oyage revenues also include the sale of bunkers consumed during short-term time charters pursuant to the terms of the time charter agreement.